{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:59:12Z","timestamp":1790143152464,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Plan Project of Guangzhou","award":["201704020168"],"award-info":[{"award-number":["201704020168"]}]},{"name":"the Science and Technology Plan Project of Guangzhou","award":["201804010259"],"award-info":[{"award-number":["201804010259"]}]},{"name":"the Science and Technology Plan Project of Guangzhou","award":["201807010064"],"award-info":[{"award-number":["201807010064"]}]},{"name":"the Science and Technology Plan Project of Guangdong Province","award":["2019B030316001"],"award-info":[{"award-number":["2019B030316001"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31771074"],"award-info":[{"award-number":["31771074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Plan Project of Liwan District, Guangzhou","award":["201804011"],"award-info":[{"award-number":["201804011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It was still unclear how homocysteine (Hcy) levels and cognitive deficits change in patients with schizophrenia of various ages. The present article attempts to assess the relationship between Hcy levels and cognitive deficits in patients with schizophrenia across age groups, especially in young people. Totals of 103 patients and 122 healthy controls were included. All participants were stratified into four groups according to their age: 18\u201329\u00a0years, 30\u201339\u00a0years, 40\u201349\u00a0years, and 50\u201359\u00a0years. Clinical data, plasma Hcy levels, and cognitive function score were collected. Cognitive function was evaluated using the MATRICS Consensus Cognitive Battery of tests assessing speed of processing, verbal learning and memory, visual learning and memory, working memory, and attention\/vigilance. Compared with the healthy group, Hcy levels increased significantly, and all the measured cognitive function score were significantly lower in all age groups of patients with schizophrenia (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Hcy levels were negatively associated with speed of processing (SoP), working memory (WM), and visual learning and memory (Vis Lrng) score in 18\u201329\u00a0years. Further multiple regression analysis showed that SoP were independently associated with Hcy levels in patients with schizophrenia aged 18\u201329\u00a0years (B\u2009=\u20090.74, t\u2009=\u20093.12, p\u2009=\u20090.008). Based on our results, patients with schizophrenia performed worse on cognitive assessments and Hcy levels were more closely related to cognition in young patients.<\/jats:p>","DOI":"10.1038\/s41598-021-99239-3","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T13:52:53Z","timestamp":1633441973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups"],"prefix":"10.1038","volume":"11","author":[{"given":"Sumiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangdong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"99239_CR1","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1056\/NEJMra1808803","volume":"381","author":"SR Marder","year":"2019","unstructured":"Marder, S. R. & Cannon, T. D. Schizophrenia. N. Engl. J. Med. 381, 1753\u20131761 (2019).","journal-title":"N. Engl. J. Med."},{"key":"99239_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/NDT.S239763","volume":"16","author":"X Huang","year":"2020","unstructured":"Huang, X. et al. Increased plasma kynurenic acid levels are associated with impaired attention\/vigilance and social cognition in patients with schizophrenia. Neuropsychiatr. Dis. Treat. 16, 263\u2013271 (2020).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"99239_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-014-0217-9","volume":"14","author":"B Jiang","year":"2014","unstructured":"Jiang, B. et al. Effects of differences in serum total homocysteine, folate, and vitamin B12 on cognitive impairment in stroke patients. BMC Neurol. 14, 217 (2014).","journal-title":"BMC Neurol."},{"key":"99239_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12020-013-9958-2","volume":"45","author":"A Bunevicius","year":"2014","unstructured":"Bunevicius, A., Kazlauskas, H., Raskauskiene, N., Janusonis, V. & Bunevicius, R. Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: A pilot study. Endocrine 45, 213\u2013220 (2014).","journal-title":"Endocrine"},{"key":"99239_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.30773\/pi.2020.0185","volume":"17","author":"YH Balcioglu","year":"2020","unstructured":"Balcioglu, Y. H. & Kirlioglu, S. S. C-reactive protein\/albumin and neutrophil\/albumin ratios as novel inflammatory markers in patients with schizophrenia. Psychiatry Investig. 17, 902\u2013910 (2020).","journal-title":"Psychiatry Investig."},{"key":"99239_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/gps.5156","volume":"34","author":"PH Chen","year":"2019","unstructured":"Chen, P. H. et al. Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder. Int. J. Geriatr. Psychiatry. 34, 1473\u20131480 (2019).","journal-title":"Int. J. Geriatr. Psychiatry."},{"key":"99239_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neubiorev.2016.08.014","volume":"69","author":"E Seti\u00e9n-Suero","year":"2016","unstructured":"Seti\u00e9n-Suero, E., Su\u00e1rez-Pinilla, M., Su\u00e1rez-Pinilla, P., Crespo-Facorro, B. & Ayesa-Arriola, R. Homocysteine and cognition: A systematic review of 111 studies. Neurosci. Biobehav. Rev. 69, 280\u2013298 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"99239_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1017\/neu.2015.30","volume":"27","author":"R Di Lorenzo","year":"2015","unstructured":"Di Lorenzo, R. et al. Homocysteine levels in schizophrenia patients newly admitted to an acute psychiatric ward. Acta Neuropsychiatr. 27, 336\u2013344 (2015).","journal-title":"Acta Neuropsychiatr."},{"key":"99239_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.arr.2018.10.010","volume":"49","author":"EA Ostrakhovitch","year":"2019","unstructured":"Ostrakhovitch, E. A. & Tabibzadeh, S. Homocysteine and age-associated disorders. Ageing Res. Rev. 49, 144\u2013164 (2019).","journal-title":"Ageing Res. Rev."},{"key":"99239_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/njcp.njcp_120_19","volume":"22","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. The relationship between plasma homocysteine levels and MTHFR gene variation, age, and sex in Northeast China. Niger. J. Clin. Pract. 22, 380\u2013385 (2019).","journal-title":"Niger. J. Clin. Pract."},{"key":"99239_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01271539","volume":"100","author":"B Regland","year":"1995","unstructured":"Regland, B., Johansson, B. V., Grenfeldt, B., Hjelmgren, L. T. & Medhus, M. Homocysteinemia is a common feature of schizophrenia. J. Neural Transm. Gen. Sect. 100, 165\u2013169 (1995).","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"99239_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jpsychires.2009.10.011","volume":"44","author":"MR Garc\u00eda-Miss","year":"2010","unstructured":"Garc\u00eda-Miss, M. R. et al. Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetr ahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia. J. Psychiatr. Res. 44, 441\u2013446 (2010).","journal-title":"J. Psychiatr. Res."},{"key":"99239_CR13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","volume":"31","author":"A Haidemenos","year":"2007","unstructured":"Haidemenos, A. et al. Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 31, 1289\u20131296 (2007).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"99239_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000342345","volume":"46","author":"A Bagney","year":"2013","unstructured":"Bagney, A. et al. Negative symptoms and executive function in schizophrenia: Does their relationship change with illness duration?. Psychopathology 46, 241\u2013248 (2013).","journal-title":"Psychopathology"},{"key":"99239_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.biopsych.2013.03.015","volume":"73","author":"S Vinogradov","year":"2013","unstructured":"Vinogradov, S., Fisher, M. & Nagarajan, S. Cognitive training in schizophrenia: Golden age or wild west?. Biol. Psychiatry. 73, 935\u2013937 (2013).","journal-title":"Biol. Psychiatry."},{"key":"99239_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12888-016-0749-1","volume":"16","author":"A Mosio Ek","year":"2016","unstructured":"Mosio Ek, A., Gierus, J., Koweszko, T. & Szulc, A. Cognitive impairment in schizophrenia across age groups: A case\u2013control study. BMC Psychiatry 16, 37 (2016).","journal-title":"BMC Psychiatry"},{"key":"99239_CR17","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1038\/s41598-020-74596-7","volume":"10","author":"R Xu","year":"2020","unstructured":"Xu, R. et al. Gender- and age-related differences in homocysteine concentration: A cross-sectional study of the general population of China. Sci. Rep. 10, 17401 (2020).","journal-title":"Sci. Rep."},{"key":"99239_CR18","first-page":"e7785","volume":"12","author":"M Omer Sultan","year":"2020","unstructured":"Omer Sultan, M. et al. Correlation of homocysteine level and age in patients with ischemic stroke. Cureus. 12, e7785 (2020).","journal-title":"Cureus."},{"key":"99239_CR19","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.1038\/s41598-020-72934-3","volume":"10","author":"Y Huang","year":"2020","unstructured":"Huang, Y. et al. Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia. Sci. Rep. 10, 16119 (2020).","journal-title":"Sci. Rep."},{"key":"99239_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/08039488.2019.1582697","volume":"73","author":"E Yazici","year":"2019","unstructured":"Yazici, E. et al. Klotho, vitamin D and homocysteine levels during acute episode and remission periods in schizophrenia patients. Nord. J. Psychiatry. 73, 178\u2013184 (2019).","journal-title":"Nord. J. Psychiatry."},{"key":"99239_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12881-015-0197-7","volume":"16","author":"S Numata","year":"2015","unstructured":"Numata, S. et al. Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian Rando Mization Analysis. BMC Med. Genet. 16, 54 (2015).","journal-title":"BMC Med. Genet."},{"key":"99239_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","volume":"8","author":"AA Moustafa","year":"2014","unstructured":"Moustafa, A. A., Hewedi, D. H., Eissa, A. M., Frydecka, D. & Misiak, B. Homocysteine levels in schizophrenia and affective disorders-focus on cognition. Front. Behav. Neurosci. 8, 343 (2014).","journal-title":"Front. Behav. Neurosci."},{"key":"99239_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00406-012-0302-2","volume":"262","author":"R Ayesa-Arriola","year":"2012","unstructured":"Ayesa-Arriola, R. et al. Homocysteine and cognition in first-episode psychosis patients. Eur. Arch. Psychiatry Clin. Neurosci. 262, 557\u2013564 (2012).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"99239_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbr.2015.01.016","volume":"283","author":"A Agrawal","year":"2015","unstructured":"Agrawal, A. et al. Age dependent levels of plasma homocysteine and cognitive performance. Behav. Brain Res. 283, 139\u2013144 (2015).","journal-title":"Behav. Brain Res."},{"key":"99239_CR25","doi-asserted-by":"publisher","first-page":"109679","DOI":"10.1016\/j.pnpbp.2019.109679","volume":"95","author":"AB TrzeNiowska-Druka","year":"2019","unstructured":"TrzeNiowska-Druka, A. B. et al. Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 95, 109679 (2019).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"99239_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12888-014-0268-x","volume":"14","author":"C Gonzalez-Liencres","year":"2014","unstructured":"Gonzalez-Liencres, C. et al. Oxidative stress in schizophrenia: A case\u2013control study on the effects on social cognition and neurocognition. BMC Psychiatry 14, 268 (2014).","journal-title":"BMC Psychiatry"},{"key":"99239_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12877-018-0876-2","volume":"18","author":"N Legdeur","year":"2018","unstructured":"Legdeur, N. et al. Age dependency of risk factors for cognitive decline. BMC Geriatr. 18, 187 (2018).","journal-title":"BMC Geriatr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99239-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:06:07Z","timestamp":1670083567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99239"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99239-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19716"}}